Search Results 1161-1170 of 16965 for monoclonal antibody

1. Laboratory Genetics - Laboratory Medicine and Pathology - Mayo Clinic

   General semen analysis, post-vasectomy analysis, antisperm antibody analysis and the assessment of individual sperm morphology are among the laboratory's work.

2. Sharing Mayo Clinic: Back from the brink

   Mayo Clinic Laboratories' comprehensive approach to targeted antibody testing played a crucial and lifesaving role in moving Sheila Lewis to recovery from ...

3. A2B101-101: Obtaining Solid Tumor Tissue from Subjects Having Surgical Resection for Certain Tumor Types and Leukapheresis for CAR T-cell Therapy Manufacturing - Mayo Clinic

   any indication, including but not limited to chemotherapy, small molecules, monoclonal antibodies, or radiotherapy (with bone marrow impact) within 2 weeks ...

4. Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ - Mayo Clinic

   History of severe allergic or anaphylactic reaction to monoclonal antibody therapy. Confirmed diagnosis of progressive multifocal leukoencephalopathy ...

5. Mayo Clinic Minute: What is CAR-T cell therapy?

   Patients who are newly diagnosed with lymphoma are offered a combination of chemotherapy and antibody-based treatments. But for those who do not respond to ...

6. A Study to Evaluate AFPᶜ³³²T in Advanced HCC - Mayo Clinic

   Prior cancer-directed immunotherapy within 4 weeks, including monoclonal antibodies against PD-1 receptor or ligand;; Use of an experimental vaccine within 2 ...

7. A Study to Evaluate the Safety, Tolerability, and Determine the Optimal Dose for the Expansion Cohorts of VSV-IFNβ-NIS in Combination with Pembrolizumab in Patients with Refractory Solid Tumors - Mayo Clinic

   Other monoclonal antibodies, antibody-drug conjugates, radioimmunoconjugates, or experimental therapies: ≤4 weeks (≤3 weeks with documented disease ...

8. A Study to Evaluate Induction Chemotherapy with ABVD Followed by Brentuximab Vedotin Consolidation in Previously-untreated, Non-bulky Stage I or II Hodgkin Lymphoma - Mayo Clinic

   For this research study, the use of brentuximab vedotin in newly diagnosed Hodgkin lymphoma is considered investigational. Brentuximab vedotin is an antibody ...

9. Combination of Serabelisib and Insulin Suppressing Diet in Subjects With Advanced Solid Tumors with PIK3CA Mutations - Mayo Clinic

   For monoclonal antibody therapy, the subject is < 1 half-life or <4 weeks from the last dose. 7. Chronic, systemically administered glucocorticoids in doses ...

10. Publications - Beth A. Ballinger, M.D. - Mayo Clinic

    Ballinger BA, Grant CS. Review of: Radiolabeled antibody imaging in the management of colorectal cancer. Results of a multicenter clinical study. Acta Chir ...